Alpha-apo-oxytetracycline;ALPHA-APO-OXYTETRACYCLINE, EP STANDARD;α-Apo-oxytetracycline;(3S)-4-cyclohexyl-2-hydroxy-3-[((2S)-2{[(2S)-2-(1-oxo-1,3-dihydroisoindol-2-yl)-3-phenylpropionyl]amino}pentanoyl)amin;4-Copab;4-Cyclohexyl-2-hydroxy-3-((2-((2-(1-oxo-1,3-dihydroisoindol-2-yl)-3-phenylpropionyl)amino)pentanoyl)amino)butyric acid isopropyl ester;alpha-Apo-oxytetracycline, 'can be used as secondary standard';Cyclohexanebutanoic acid,b-[[2-[[2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-1-oxo-3-phenylpropyl]amino]-1-oxopentyl]amino]-a-hydroxy-,1-methylethyl ester,[aR-[aR*,bS*[S*(S*)]]]-(9CI);α-ApoterraMycin;a-Apo-oxytetracycline;BETA-APO-OXYTETRACYCLINE;ALPHA-APO-OXYTETRACYCLINE;Apooxytetracycline, alpha-;Oxytetracycline EP Impurity D;Cefamandole Sodium Impurity 5;α-Apo-oxytetracycline, 'can be used as secondary standard;4-(1,3-Dihydro-4,5-dihydroxy-9-Methyl-3-oxonaphtho[2,3-c]furan-1-yl)-3-(diMethylaMino)-2,5-dihydroxy-6-oxo-1-cyclohexene-1-carboxaMideOpen